ORSERDU 86 mg/1
Elacestrant · TABLET, FILM COATED · Stemline Therapeutics, Inc.
No Recall History
Plain English
ORSERDU is a tablet, film coated containing elacestrant at 86 mg/1, taken oral. Manufactured by Stemline Therapeutics, Inc..
Key Facts
- Brand Name
- ORSERDU
- Generic Name
- Elacestrant
- NDC Code (Product)
72187-0101- Manufacturer
- Stemline Therapeutics, Inc.
- Strength
- 86 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA217639
- Drug Class
- Estrogen Receptor Antagonist [EPC]
- Marketing Start
- 01/27/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is ORSERDU used for?
ORSERDU contains Elacestrant. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is ORSERDU a controlled substance?
ORSERDU is not classified as a controlled substance by the DEA.
What is the generic name for ORSERDU?
The generic name for ORSERDU is Elacestrant. There are no other listed brand versions of Elacestrant.
What is the NDC code for ORSERDU 86 mg/1?
The NDC (National Drug Code) for ORSERDU 86 mg/1 is 72187-0101, listed by Stemline Therapeutics, Inc..
Other ORSERDU Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)